Increase of CD26/dipeptidyl peptidase IV expression on human gingival fibroblasts upon stimulation with cytokines and bacterial components.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 97023)

Published in Infect Immun on December 01, 1999

Authors

E Nemoto1, S Sugawara, H Takada, S Shoji, H Horiuch

Author Affiliations

1: Department of Endodontics and Periodontics, Tohoku University School of Dentistry, Sendai, 980-8575, Japan. eiji@mail.cc.tohoku.ac.jp

Articles cited by this

Real time quantitative PCR. Genome Res (1996) 35.79

A novel method for real time quantitative RT-PCR. Genome Res (1996) 15.83

Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol (1986) 10.92

Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med (1990) 7.49

Interleukin 1, a potential regulator of fibroblast proliferation. J Immunol (1982) 6.05

Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol (1997) 2.47

Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression. J Immunol (1985) 2.27

Evidence of fibroblast heterogeneity and the role of fibroblast subpopulations in fibrosis. Clin Immunol Immunopathol (1994) 1.83

Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key! Blood (1993) 1.77

Induction of interleukin-1 and -6 in human gingival fibroblast cultures stimulated with Bacteroides lipopolysaccharides. Infect Immun (1991) 1.73

Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage. J Exp Med (1997) 1.67

Proline-dependent structural and biological properties of peptides and proteins. Crit Rev Biochem Mol Biol (1993) 1.54

Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection. J Biol Chem (1998) 1.53

Lipopolysaccharides of Bacteroides intermedius (Prevotella intermedia) and Bacteroides (Porphyromonas) gingivalis induce interleukin-8 gene expression in human gingival fibroblast cultures. Infect Immun (1992) 1.49

Psoriasis: a disease of abnormal Keratinocyte proliferation induced by T lymphocytes. Immunol Today (1986) 1.36

Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. J Immunol (1991) 1.33

CD26: a surface protease involved in T-cell activation. Immunol Today (1994) 1.29

The role of dipeptidyl peptidase IV in human T lymphocyte activation. Inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro. Eur J Immunol (1987) 1.24

Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): a possible mechanism for Tat's immunosuppressive activity. Proc Natl Acad Sci U S A (1994) 1.23

Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage. Proc Natl Acad Sci U S A (1998) 1.15

Cell-surface peptidases as modulators of growth and differentiation. Lancet (1989) 1.13

Bacteroides lipopolysaccharides (LPS) induce anaphylactoid and lethal reactions in LPS-responsive and -nonresponsive mice primed with muramyl dipeptide. J Infect Dis (1990) 1.11

Lipopolysaccharides of oral anaerobes associated with chronic inflammation: chemical and immunomodulating properties. Int Rev Immunol (1990) 1.11

Heterogeneous expression and release of CD14 by human gingival fibroblasts: characterization and CD14-mediated interleukin-8 secretion in response to lipopolysaccharide. Infect Immun (1998) 1.09

Mucosal and systemic immune responses in BALB/c mice to Bacteroides gingivalis fimbriae administered orally. Infect Immun (1989) 1.05

Dipeptidyl peptidase IV in human T lymphocytes. Impaired induction of interleukin 2 and gamma interferon due to specific inhibition of dipeptidyl peptidase IV. Scand J Immunol (1989) 0.97

Regulation of periodontal ligament cell functions by interleukin-1beta. Infect Immun (1998) 0.94

Diprotins A and B, inhibitors of dipeptidyl aminopeptidase IV, produced by bacteria. J Antibiot (Tokyo) (1984) 0.94

Suppression of arthritis by the inhibitors of dipeptidyl peptidase IV. Int J Immunopharmacol (1997) 0.89

A novel component different from endotoxin extracted from Prevotella intermedia ATCC 25611 activates lymphoid cells from C3H/HeJ mice and gingival fibroblasts from humans. Infect Immun (1997) 0.89

Characterization of specific proteases associated with the surface of human skin fibroblasts, and their modulation in pathology. J Cell Physiol (1992) 0.89

Antigen-presenting-cell function of interferon gamma-treated human gingival fibroblasts. J Periodontal Res (1996) 0.86

Granulocyte-macrophage colony-stimulating factor expression by human fibroblasts is both upregulated and subsequently downregulated by interleukin-1. Blood (1995) 0.83

Cathepsin B/L-, elastase-, tryptase-, trypsin- and dipeptidyl peptidase IV-like activities in gingival crevicular fluid. A comparison of levels before and after basic periodontal treatment of chronic periodontitis patients. J Clin Periodontol (1992) 0.82

Cathepsin B/L-, elastase-, tryptase-, trypsin- and dipeptidyl peptidase IV-like activities in gingival crevicular fluid: correlation with clinical parameters in untreated chronic periodontitis patients. J Periodontal Res (1992) 0.81

Expression of ectopeptidases in scleroderma. Ann Rheum Dis (1995) 0.77

Histochemical and immunocytochemical localization of dipeptidyl peptidases II and IV in human gingiva. J Periodontol (1996) 0.77

Scleroderma-derived human fibroblasts retain abnormal phenotypic and functional characteristics following retroviral transduction with the SV40 tsT antigen. Exp Cell Res (1995) 0.76

Articles by these authors

Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity (1999) 17.40

Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature (1999) 6.23

n-Tetradecanoyl is the NH2-terminal blocking group of the catalytic subunit of cyclic AMP-dependent protein kinase from bovine cardiac muscle. Proc Natl Acad Sci U S A (1982) 4.51

Comparison of a polymerase chain reaction assay and a conventional microbiologic method for detection of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1992) 4.14

Complete amino acid sequence of the catalytic subunit of bovine cardiac muscle cyclic AMP-dependent protein kinase. Proc Natl Acad Sci U S A (1981) 3.07

Purification and properties of chromosomally mediated beta-lactamase from Citrobacter freundii GN7391. J Gen Microbiol (1980) 2.28

Amino acid sequence of the catalytic subunit of bovine type II adenosine cyclic 3',5'-phosphate dependent protein kinase. Biochemistry (1983) 2.18

Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin-paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002). Ann Oncol (2012) 2.17

Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture. Cell Microbiol (2005) 2.07

Synthetic lipid A with endotoxic and related biological activities comparable to those of a natural lipid A from an Escherichia coli re-mutant. Infect Immun (1985) 2.04

Purification and properties of beta-lactamase from Proteus morganii. J Bacteriol (1977) 1.96

Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer. Br J Surg (1990) 1.75

Studies on orally active cephalosporin esters. J Antibiot (Tokyo) (1987) 1.72

Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture. Infect Immun (2001) 1.71

Outbreak of severe neurologic involvement associated with Enterovirus 71 infection. Pediatr Neurol (1999) 1.71

Plastic resin pellets as a transport medium for toxic chemicals in the marine environment. Environ Sci Technol (2001) 1.70

Pulmonary macrophages can stimulate cell growth of bovine bronchial epithelial cells. Am J Respir Cell Mol Biol (1990) 1.66

Sequence of two phosphorylated sites in the catalytic subunit of bovine cardiac muscle adenosine 3':5'-monophosphate-dependent protein kinase. J Biol Chem (1979) 1.66

Macrophage activation by bacterial cell walls and related synthetic compounds. Infect Immun (1979) 1.63

Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia. Proc Natl Acad Sci U S A (1999) 1.61

Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells. J Immunol (2001) 1.60

Metallosis due to impingement between the socket and the femoral neck in a metal-on-metal bearing total hip prosthesis. A case report. J Bone Joint Surg Am (1999) 1.60

Immunobiologically active lipid A analogs synthesized according to a revised structural model of natural lipid A. Infect Immun (1984) 1.57

Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification. Clin Cancer Res (2001) 1.55

Cytoplasmic and nuclear polyglutamine aggregates in SCA6 Purkinje cells. Neurology (2001) 1.53

Predominant activation and expansion of V gamma 9-bearing gamma delta T cells in vivo as well as in vitro in Salmonella infection. J Clin Invest (1992) 1.52

Absence of colorectal cancer metastasis to the cirrhotic liver. Am J Surg (1992) 1.51

CSF hypocretin levels in Guillain-Barré syndrome and other inflammatory neuropathies. Neurology (2003) 1.50

Lipopolysaccharides of Bacteroides intermedius (Prevotella intermedia) and Bacteroides (Porphyromonas) gingivalis induce interleukin-8 gene expression in human gingival fibroblast cultures. Infect Immun (1992) 1.49

Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. Kidney Int (1999) 1.45

Acid and alkaline invertases in suspension cultures of sugar beet cells. Plant Physiol (1988) 1.44

Detection of methicillin-resistant Staphylococcus aureus (MRSA) using polymerase chain reaction amplification. Tohoku J Exp Med (1991) 1.44

The effect of cortisone on protein breakdown and synthesis in rat skeletal muscle. Mol Cell Endocrinol (1977) 1.43

Long-term observation of a manic-depressive patient with rapid cycles. Biol Psychiatry (1991) 1.39

New cephamycin antibiotic, CS-1170: binding affinity to penicillin-binding proteins and inhibition of peptidoglycan cross-linking reactions in Escherichia coli. Antimicrob Agents Chemother (1978) 1.37

Mitogenic effects of bacterial cell walls, their fragments, and related synthetic compounds on thymocytes and splenocytes of guinea pigs. Infect Immun (1979) 1.36

Age-related variation in the proportion and activity of murine liver natural killer cells and their cytotoxicity against regenerating hepatocytes. J Immunol (1988) 1.35

Characterization of Ca(2+) signaling pathways in human mesenchymal stem cells. Cell Calcium (2002) 1.33

Erythromycin suppresses interleukin 6 expression by human bronchial epithelial cells: a potential mechanism of its anti-inflammatory action. Biochem Biophys Res Commun (1995) 1.33

Involvement of NK1+ T cells and their IFN-gamma production in the generalized Shwartzman reaction. J Immunol (1998) 1.32

Cytokine-inducing glycolipids in the lipoteichoic acid fraction from Enterococcus hirae ATCC 9790. FEMS Immunol Med Microbiol (1995) 1.30

Chicken oocyte growth is mediated by an eight ligand binding repeat member of the LDL receptor family. EMBO J (1994) 1.29

Purification and Some Properties of Cell Wall-bound Invertases from Sugar Beet Seedlings and Aged Slices of Mature Roots. Plant Physiol (1980) 1.28

Quantitative analysis of nodal involvement with respect to survival rate after curative gastrectomy for carcinoma. Surg Gynecol Obstet (1990) 1.27

Abeta1-40 but not Abeta1-42 levels in cortex correlate with apolipoprotein E epsilon4 allele dosage in sporadic Alzheimer's disease. Brain Res (1997) 1.27

Induction of human TCR gamma delta + and TCR gamma delta-CD2+CD3- double negative lymphocytes by bacterial stimulation. Int Immunol (1990) 1.26

Penicillin-binding proteins in Proteus species. J Bacteriol (1979) 1.26

Mitogenic activity of adjuvant-active N-acetylmuramyl-L-alanyl-D-isoglutamine and its analogues. Biken J (1977) 1.25

An extraskeletal osteosarcoma in an aged rat. Nihon Juigaku Zasshi (1988) 1.24

Enhancement of human hepatocyte growth factor production by interleukin-1 alpha and -1 beta and tumor necrosis factor-alpha by fibroblasts in culture. J Biol Chem (1993) 1.24

Immunopharmacological activities of a synthetic counterpart of a biosynthetic lipid A precursor molecule and of its analogs. Infect Immun (1985) 1.22

Proteolysis of human monocyte CD14 by cysteine proteinases (gingipains) from Porphyromonas gingivalis leading to lipopolysaccharide hyporesponsiveness. J Immunol (2000) 1.22

Lipopolysaccharide promotes and augments metal allergies in mice, dependent on innate immunity and histidine decarboxylase. Clin Exp Allergy (2007) 1.21

Immunoadjuvant activities of synthetic 6-O-acyl-N-acetylmuramyl-L-alanyl-D-isoglutamine with special reference to the effect of its administration with liposomes. Biken J (1977) 1.21

Toll-like receptors, NOD1, and NOD2 in oral epithelial cells. J Dent Res (2006) 1.19

Immunobiological activities of synthetic lipid A analogs and related compounds as compared with those of bacterial lipopolysaccharide, re-glycolipid, lipid A, and muramyl dipeptide. Infect Immun (1983) 1.19

APP717 missense mutation affects the ratio of amyloid beta protein species (A beta 1-42/43 and a beta 1-40) in familial Alzheimer's disease brain. J Biol Chem (1994) 1.18

Characterization of gyrA, gyrB, grlA and grlB mutations in fluoroquinolone-resistant clinical isolates of Staphylococcus aureus. J Antimicrob Chemother (1998) 1.17

Chemically synthesized pathogen-associated molecular patterns increase the expression of peptidoglycan recognition proteins via toll-like receptors, NOD1 and NOD2 in human oral epithelial cells. Cell Microbiol (2005) 1.16

Low endotoxic activities of synthetic Salmonella-type lipid A with an additional acyloxyacyl group on the 2-amino group of beta (1-6) glucosamine disaccharide 1,4'-bisphosphate. Infect Immun (1986) 1.16

Theiler's murine encephalomyelitis virus subgroup strain-specific infection in a murine macrophage-like cell line. J Virol (1997) 1.14

Selective phagocytosis of gram-positive bacteria and interleukin 1-like factor production by a subpopulation of large granular lymphocytes. J Immunol (1986) 1.14

Abundant expression and cytoplasmic aggregations of [alpha]1A voltage-dependent calcium channel protein associated with neurodegeneration in spinocerebellar ataxia type 6. Hum Mol Genet (1999) 1.12

Distinct gene expression patterns of peripheral blood cells in hyper-IgE syndrome. Clin Exp Immunol (2005) 1.12

Lipopolysaccharides of oral anaerobes associated with chronic inflammation: chemical and immunomodulating properties. Int Rev Immunol (1990) 1.11

Radiotelemetry of the pH of the gastrointestinal tract by glass electrode. Gastroenterology (1966) 1.11

Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double-blind, placebo-controlled trial. Diabet Med (2011) 1.10

Identification of novel MUNC13-4 mutations in familial haemophagocytic lymphohistiocytosis and functional analysis of MUNC13-4-deficient cytotoxic T lymphocytes. J Med Genet (2004) 1.10

Heterogeneous expression and release of CD14 by human gingival fibroblasts: characterization and CD14-mediated interleukin-8 secretion in response to lipopolysaccharide. Infect Immun (1998) 1.09

Amyloid beta protein in plasma from patients with sporadic Alzheimer's disease. J Neurol Sci (1996) 1.08

Proapoptotic activity of Caenorhabditis elegans CED-4 protein in Drosophila: implicated mechanisms for caspase activation. Proc Natl Acad Sci U S A (1999) 1.08

Gingipains from Porphyromonas gingivalis synergistically induce the production of proinflammatory cytokines through protease-activated receptors with Toll-like receptor and NOD1/2 ligands in human monocytic cells. Cell Microbiol (2008) 1.08

Nucleotide sequence and cloning in Bacillus subtilis of the Bacillus stearothermophilus pleiotropic regulatory gene degT. J Bacteriol (1990) 1.08

Functional TLRs and NODs in human gingival fibroblasts. J Dent Res (2007) 1.07

Enhancement by galactosamine of lipopolysaccharide(LPS)-induced tumour necrosis factor production and lethality: its suppression by LPS pretreatment. Br J Pharmacol (1999) 1.07

Effect of dietary eicosapentaenoic acid on azoxymethane-induced colon carcinogenesis in rats. Cancer Res (1988) 1.06

Electrophoretic patterns of proteins in the blastocoelic fluid of the rabbit following ovariectomy. Anat Rec (1967) 1.06

Malignant hemangioendothelioma of the small intestine: report of a case. Surg Today (1999) 1.05

Acute subarachnoid hemorrhage: MR imaging with fluid-attenuated inversion recovery pulse sequences. Radiology (1995) 1.05

Structural feature of the major but not cytokine-inducing molecular species of lipoteichoic acid. J Biochem (1997) 1.05

An analogue of lipid A and LPS from Rhodobacter sphaeroides inhibits neutrophil responses to LPS by blocking receptor recognition of LPS and by depleting LPS-binding protein in plasma. J Leukoc Biol (1995) 1.04

Requirement of a properly acylated beta(1-6)-D-glucosamine disaccharide bisphosphate structure for efficient manifestation of full endotoxic and associated bioactivities of lipid A. Infect Immun (1987) 1.03

Clinical, neuropathological, and molecular study in two families with spinocerebellar ataxia type 6 (SCA6). J Neurol Neurosurg Psychiatry (1999) 1.03

Plasma levels of amyloid beta proteins Abeta1-40 and Abeta1-42(43) are elevated in Down's syndrome. Ann Neurol (1997) 1.03

Effects of scatter and attenuation correction on quantitative assessment of regional cerebral blood flow with SPECT. J Nucl Med (1998) 1.03

Molecular analysis of the Duchenne muscular dystrophy gene in patients with Becker muscular dystrophy presenting with dilated cardiomyopathy. Muscle Nerve (1993) 1.03

Abeta42-positive non-pyramidal neurons around amyloid plaques in Alzheimer's disease. Lancet (2000) 1.03

Enhancement of endotoxin lethality and generation of anaphylactoid reactions by lipopolysaccharides in muramyl-dipeptide-treated mice. Infect Immun (1987) 1.03

Unique activation status of peripheral blood mononuclear cells at acute phase of Kawasaki disease. Clin Exp Immunol (2009) 1.03

Endotoxin stimulates bronchial epithelial cells to release chemotactic factors for neutrophils. A potential mechanism for neutrophil recruitment, cytotoxicity, and inhibition of proliferation in bronchial inflammation. J Immunol (1991) 1.02

Double contrast radiograph on routine examination of the stomach. Am J Gastroenterol (1970) 1.01

Endocrine cells and prognosis in patients with colorectal carcinoma. Cancer (1992) 1.01

Synergism between TLRs and NOD1/2 in oral epithelial cells. J Dent Res (2008) 1.01

Absorption, distribution, excretion and metabolism of cefmetazole in cynomolgus monkeys. J Antibiot (Tokyo) (1982) 1.00

The purification, characterization, cloning and sequencing of the gene for a halostable and thermostable leucine dehydrogenase from Thermoactinomyces intermedius. Eur J Biochem (1994) 1.00